Brain Aging: How Epigenetic Changes Affect Gene Control in the Brain

Aging isn’t simply wear and tear; it’s a gradual loss of control over how our genes are regulated, a recent study in mice suggests. Researchers have created the most detailed epigenetic atlas of the brain to date, mapping chemical tags that control gene expression and revealing how these tags change with age. This research, published in the journal Cell, offers a crucial step toward understanding brain aging and potentially identifying ways to slow or even reverse some of its effects.

How Epigenetic Changes Impact Brain Function

Our DNA sequence is the same in nearly every cell in our body, yet cells perform vastly different functions. What we have is because of epigenetics – chemical modifications to DNA that dictate which genes are turned on or off. These epigenetic markers aren’t changes to the DNA sequence itself, but rather instructions that tell a cell *how* to use its DNA. As we age, these epigenetic markers change, and this can disrupt the delicate balance of gene expression necessary for healthy brain function.

The study, led by researchers at the Salk Institute, examined the brains of mice at different ages – young adulthood (2 months), adulthood (9 months), and old age (18 months). They analyzed over 200,000 cells, creating a high-resolution map of epigenetic changes across different brain regions. One key finding was a decrease in DNA methylation, a process where a chemical tag is added to DNA to typically switch genes “off.” As methylation decreases with age, genes can develop into inappropriately activated.

“It shows that aging isn’t just wear and tear; it’s a loss of control over how genes are regulated,” said David Sinclair, a geneticist at Harvard University who was not involved in the study. Sinclair emphasizes the importance of this finding, as it shifts the focus from simply repairing damage to restoring regulatory control.

Jumping Genes and the Aging Brain

The researchers discovered that the loss of methylation particularly affected “jumping genes,” similarly known as transposons. These are repetitive DNA sequences that can move around the genome, potentially disrupting the function of other genes. Normally, methylation keeps these jumping genes in check. As methylation declines with age, these genes become more active, potentially triggering immune responses that can damage brain cells. Learn more about jumping genes here.

This activation of jumping genes appears to be linked to changes in chromatin structure, the way DNA is packaged within the nucleus. The study found that aging brains exhibited more tightly packed chromatin, forming additional loops called topologically associated domains (TADs). These TADs can further restrict gene expression and contribute to the overall disruption of brain function.

Implications for “Super-Agers” and Alzheimer’s Disease

Interestingly, the researchers noted that individuals who maintain cognitive function well into old age – often referred to as “super-agers” – may have lower levels of jumping gene activation. A recent study in Nature found that super-agers have more precursor cells in brain regions responsible for memory. You can read more about the Nature study here. This suggests that maintaining control over jumping genes could be a key factor in preserving cognitive health.

The findings also have implications for neurodegenerative diseases like Alzheimer’s. While the study was conducted in mice, the researchers believe that similar epigenetic changes likely occur in the human brain. Understanding these changes could lead to new strategies for preventing or treating Alzheimer’s and other age-related cognitive decline.

Epigenetic Clocks and Biological Age

This research builds upon the growing field of “epigenetic clocks,” which use patterns of DNA methylation to estimate biological age – how old your body is, compared to your chronological age. Epigenetic clocks are increasingly used as biomarkers of aging, and can even predict health outcomes. The new study provides a more detailed understanding of the epigenetic changes that drive these clocks, particularly in the brain.

Researchers from the Chinese Academy of Sciences and Monash University have also developed new tools to measure biological aging at the level of individual cell types. Read more about cell-type specific epigenetic clocks here. This is important because different cell types age at different rates, and understanding these differences is crucial for developing targeted therapies.

What Comes Next: Sequencing the Human Brain

The current study provides a valuable roadmap for future research. The researchers are now working to apply these techniques to the human brain, which is far more complex than the mouse brain. Sequencing the human brain’s epigenome will be a massive undertaking, but it could unlock new insights into the aging process and pave the way for interventions that promote healthy brain aging. The team also plans to investigate whether lifestyle factors, such as diet and exercise, can influence epigenetic changes and slow down brain aging.

The study, titled “Cell-type-specific transposon demethylation and TAD remodeling in aging mouse brain,” was published in Cell on February 26, 2026. You can find the full study here.

Zeng, Q., Wang, W., Tian, W., Klein, A., Bartlett, A., Liu, H., Nery, J. R., Castanon, R. G., Osteen, J., Johnson, N. D., Ding, W., Chen, H., Altshul, J., Kenworthy, M., Valadon, C., Owens, W., Wu, Z., Amaral, M. L., Zemke, N. R., . . . Ecker, J. R. (2026). Cell-type-specific transposon demethylation and TAD remodeling in aging mouse brain. Cell. https://doi.org/10.1016/j.cell.2026.02.015